Literature DB >> 8724619

An evaluation of the copper-T 380A IUD's safety and efficacy at three African centers.

G Farr1, R Amatya, A Doh, C C Ekwempu, M Toppozada, J Ruminjo.   

Abstract

The use of intrauterine devices in Africa is low compared with other contraceptive methods such as oral contraceptives. This study, coordinated by Family Health International, evaluated the clinical performance (safety and efficacy) of the TCu 380A IUD in three African centers, respectively, in Cameroon, Egypt, and Nigeria from 1986-1989. The 12-month unintended pregnancy rates were low for all three centers, ranging from none to 1.6 per 100 women. The 12-month discontinuation rates for all reasons ranged from 8.8 to 26.9 per 100 women. Statistically significant differences were observed among clinics for discontinuation rates for bleeding and/or pain and for planned pregnancy. The overall performance of the TCu 380A IUDs was considered satisfactory. Thus, the limited use of IUD in Africa could be due to the lack of accessibility, lack of information about, and confidence in the method rather than to documented clinical performance.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Arab Countries; Cameroon; Clinical Research; Clinical Trials; Contraception; Contraceptive Effectiveness; Contraceptive Methods; Contraceptive Usage; Developing Countries; Egypt; English Speaking Africa; Family Planning; French Speaking Africa; Health; Iud; Iud, Copper Releasing; Mediterranean Countries; Method Acceptability; Middle Africa; Nigeria; Northern Africa; Public Health; Research Methodology; Research Report; Safety; Western Africa

Mesh:

Year:  1996        PMID: 8724619

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  1 in total

1.  Magnetic field interactions of copper-containing intrauterine devices in 3.0-Tesla magnetic resonance imaging: in vivo study.

Authors:  Vanessa Berger-Kulemann; Henrik Einspieler; Nilouparak Hachemian; Daniela Prayer; Siegfried Trattnig; Michael Weber; Ahmed Ba-Ssalamah
Journal:  Korean J Radiol       Date:  2013-05-02       Impact factor: 3.500

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.